Skip to main content
AMGN
NASDAQ Life Sciences

Amgen to Negotiate Enbrel Prices Under IRA, Targeting $1.5B Medicare Savings

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$363.374
Mkt Cap
$195.883B
52W Low
$261.43
52W High
$391.29
52W Position info
39% above low
Off High info
7.1% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

AMGN sits 39% above its 52-week low of $261.43.

Summary

Amgen's Immunex subsidiary will enter negotiations for Enbrel prices under the Inflation Reduction Act, a move expected to save Medicare enrollees approximately $1.5 billion in 2026. This development signals a direct financial impact from the IRA's drug pricing provisions, potentially reducing revenue for Amgen from one of its key products. Separately, the company's Board of Directors declared a routine quarterly dividend of $2.52 per share for Q2 2026, payable on June 5, 2026. While the dividend is a standard capital allocation, the Enbrel price negotiation represents a material regulatory headwind that traders will monitor for its effect on future earnings.

At the time of this announcement, AMGN was trading at $363.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $195.9B. The 52-week trading range was $261.43 to $391.29. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $458.60 info
Change: -$18.80 (-4%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $458.60 info
Change: -$6.32 (-1%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $458.60 info
Change: -$4.40 (-0.95%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $458.60 info
Change: -$1.97 (-0.43%) info
Market Cap: $248.842B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $458.60 info
Change: +$9.81 (+2%) info
Market Cap: $248.842B info